| scholarly article | Q13442814 |
| P356 | DOI | 10.1148/RADIOL.2342031202 |
| P698 | PubMed publication ID | 15671002 |
| P50 | author | Andrea Laghi | Q38549464 |
| Francesca Piacentini | Q57945941 | ||
| P2093 | author name string | Carlo Catalano | |
| Roberto Passariello | |||
| Masatoshi Hori | |||
| Italo Nofroni | |||
| Takamichi Murakami | |||
| Filippo Mangiapane | |||
| Riccardo Iannaccone | |||
| Plinio Rossi | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| liver cirrhosis | Q147778 | ||
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 460-467 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Hepatocellular Carcinoma: Role of Unenhanced and Delayed Phase Multi–Detector Row Helical CT in Patients with Cirrhosis | |
| P478 | volume | 234 |
| Q37646457 | Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma. |
| Q89402120 | An Intravascular Tantalum Oxide-based CT Contrast Agent: Preclinical Evaluation Emulating Overweight and Obese Patient Size |
| Q38891523 | Assessment of Added Value of Noncontrast to Contrast-Enhanced Abdominal Computed Tomography Scan for Characterization of Hypervascular Liver Metastases. |
| Q26770014 | CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review |
| Q34681076 | CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects |
| Q34682228 | CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features |
| Q45913435 | CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase. |
| Q31140344 | Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography |
| Q35175972 | Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans |
| Q38541176 | Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study |
| Q28082223 | Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma |
| Q37652891 | Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity |
| Q36531325 | Current staging of hepatocellular carcinoma: imaging implications |
| Q36524356 | Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver |
| Q53581170 | Diagnosis of small hepatocellular carcinoma. |
| Q53012725 | Differentiation of small arterial enhancing hepatocellular carcinoma from non-tumorous arterioportal shunt with an emphasis on the precontrast CT scan. |
| Q35093307 | Dynamic multidetector computed tomography findings of hepatocellular carcinoma of hepatitis B virus-positive and -negative patients |
| Q36365466 | Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation. |
| Q37345845 | Guidelines for imaging focal lesions in liver cirrhosis |
| Q36324663 | Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. |
| Q56741838 | Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT |
| Q37899101 | Imaging diagnosis and staging of hepatocellular carcinoma |
| Q37122567 | Imaging in liver transplantation |
| Q26768463 | Imaging of HCC-Current State of the Art |
| Q24654739 | Imaging of liver cancer |
| Q53540827 | Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography. |
| Q87145592 | Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? |
| Q43906532 | LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound |
| Q36912160 | Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis |
| Q53330856 | Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. |
| Q53079586 | Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. |
| Q44043742 | Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography |
| Q40602654 | Post liver transplant presentation of needle-track metastasis of hepatocellular carcinoma following percutaneous liver biopsy |
| Q30432108 | Pretreatment assessment of hepatocellular carcinoma: expert consensus statement |
| Q43954477 | Radiological diagnosis of primary hepatic malignancy |
| Q37118064 | SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings |
| Q43002617 | Serine- and mannose-modified liposomal contrast agent for computed tomography: evaluation of the enhancement in rabbit liver VX-2 tumor model |
| Q36326113 | Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. |
| Q48372312 | Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT. |
| Q50931672 | Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI. |
| Q35108961 | Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography |
| Q41208415 | The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma. |
| Q60929481 | The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer |
| Q42201891 | The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area |
| Q52940264 | Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients. |
| Q53062572 | Utility of non-contrast-enhanced CT for improved detection of arterial phase hyperenhancement in hepatocellular carcinoma. |
Search more.